Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bioderma Atoderm SOS spray
- Development stage
- Unknown
- Lead developer
- NAOS
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical
01
Overview
Bioderma Atoderm SOS spray is a topical dermatological product designed to provide rapid relief from itching (pruritus) and discomfort associated with irritated, dry to very dry, and atopic skin. The formulation features Skin Relief technology (containing Ambora and green tea extracts) combined with enoxolone (glycyrrhetinic acid), which targets the biological pathways responsible for itching by acting directly on skin cells. The patented Skin Barrier Therapy complex helps limit the adhesion of Staphylococcus aureus bacteria, reducing the risk of aggravating skin dryness. Additional ingredients such as niacinamide and squalane help restore lipids and strengthen the skin barrier. The product is non-comedogenic, unfragranced, suitable for all ages except premature infants, and provides immediate comfort with effects lasting up to 6 hours[1][4][8][9].
- Brand names
- Bioderma Atoderm SOS spray
- Other names
- Atoderm SOS SprayAtoderm SOS Anti-Itching Spray
02
Targets
GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on Bioderma Atoderm SOS spray.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bioderma Atoderm SOS spray.